Robert Orlowski, Florence Maude Thomas Cancer Research Professor at The University of Texas MD Anderson Cancer Center, shared a post on X:
“Myeloma Paper of the Day: Transplant eligible newly diagnosed myeloma patients with t(11;14) have inferior outcomes compared with standard risk patients when receiving induction therapy with VTD, though not if they get VRD induction therapy.”
Authors: David Moreno, Albert Oriol, Javier de la Rubia, Joan Bladé, Laura Rosiñol et al.
More posts featuring Robert Orlowski.
